Mandate

Gilde Investment Management BV – sale of Plastal Holding AB to Nordic Capital

May 11, 2005

Nordic Capital, the Swedish private equity firm and the management of Plastal, the Swedish supplier of automotive components, have agreed to acquire the company from Gilde Investment Management, the Dutch private equity firm, in a management buy out transaction with an undisclosed value. The management, led by CEO Christer Palm, will hold a 18% stake in Plastal while Nordic will hold the remaining 82%.

Vinge acted for Gilde Investment Management BV.
Peter Linderoth, Björn Mullaart (reponsible partners)
Sofia Olsson, Emma Olnäs (associates)

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026